Algen Biotechnologies
New accelerator entry · 2025-10-06 · the record
In their words
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Algen Biotechnologies
- Source Check — verify what Algen Biotechnologies states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Algen Biotechnologies for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Algen BiotechnologiesYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Algen Biotechnologies: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.